Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix

NCT: NCT02518594 · COMPLETED

NCT IDNCT02518594
StatusCOMPLETED
Start Date2015-11-13
Completion2025-02-18
SponsorThe George Washington University Biostatistics Center (OTHER)
First posted
Last updated

Brief Summary

This protocol outlines a randomized trial of 630 women evaluating the use of micronized vaginal progesterone or pessary versus control (placebo) to prevent early preterm birth in women carrying twins and with a cervical length of less than 30 millimeters.

Frequently Asked Questions

What is A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix?

A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix is a clinical trial registered under NCT02518594. Current status: COMPLETED.

What is the status of NCT02518594?

The current status of NCT02518594 (A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix) is: COMPLETED.

When did A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix start?

A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix started on 2015-11-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑